1. The efficacy and safety of various dose-dense regimens of temozolomide for recurrent high-grade glioma: a systematic review with meta-analysis
   Wei Wei et al, 2015, Journal of Neuro-Oncology CrossRef
2. Therapeutic Immunization against Glioblastoma
   Virgil Schijns et al, 2018, International Journal of Molecular Sciences CrossRef
3. Therapeutic options in recurrent glioblastoma—An update
   Katharina Seystahl et al, 2016, Critical Reviews in Oncology/Hematology CrossRef
4. Current Standards of Care in Glioblastoma Therapy
   null null et al, 2017, Glioblastoma CrossRef
5. Evaluation of two-stage designs of Phase 2 single-arm trials in glioblastoma: a systematic review
   Wonsuk Yoo et al, 2022, BMC Medical Research Methodology CrossRef
6. Metronomics: towards personalized chemotherapy?
   Nicolas André et al, 2014, Nature Reviews Clinical Oncology CrossRef
7. Incorporation of biomarkers in phase II studies of recurrent glioblastoma
   Toni Rose Jue et al, 2015, Tumor Biology CrossRef
8. Administration of temozolomide: Comparison of conventional and metronomic chemotherapy regimens
   Nicolas Houy et al, 2018, Journal of Theoretical Biology CrossRef